Avalon GloboCare (ALBT) Stock Analysis & Winston Score

Avalon GloboCare Corp. is a small company that has operated across two main areas: real estate services in China and the United States, and earlier-stage work in cell therapy and medical technology. Its real estate segment helps clients buy, sell, and manage properties, primarily targeting Chinese investors and buyers interested in U.S. real estate. The company has gone through significant strategic shifts over the years, making it difficult to pin down a single defining business. Avalon generates revenue through real estate brokerage commissions and related services, with operations centered in the U.S. and China. The company is very small, with a market cap near zero, and the unusual margin figures reflect its tiny revenue base rather than a strong business model. The deeply negative return on invested capital signals that the company is destroying value, and its biggest risk is simply staying financially viable — it has a history of losses, strategic pivots, and limited scale that make long-term stability uncertain.